Schedule 13D ownership disclosure

BIOMX INC

Common Stock, par value $0.0001 per share · CUSIP: 09090D103

Event date: 2025-02-27

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Deerfield Private Design Fund V, L.P.Reported CIK 0001815437

    Shares: 7,779,222.00 · Class: 9.99%

  • Deerfield Mgmt V, L.P.Reported CIK 0001876688

    Shares: 7,779,222.00 · Class: 9.99%

  • Deerfield Healthcare Innovations Fund II, L.P.Reported CIK 0001780064

    Shares: 7,779,222.00 · Class: 9.99%

  • Deerfield Mgmt HIF II, L.P.Reported CIK 0001665736

    Shares: 7,779,222.00 · Class: 9.99%

  • Deerfield Management Company, L.P.Reported CIK 0001009258

    Shares: 15,558,445.00 · Class: 9.99%

  • James E. FlynnReported CIK 0001352546

    Shares: 15,558,445.00 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-25-000259
Form type
SCHEDULE 13D/A
Filer
BiomX Inc.
CIK
CIK 1739174
Filed
Mar 03, 2025
Reporting period
Feb 27, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub